The agreement covers novel classes of antibiotics resulting from Rib-X’s RX-04 program which have demonstrated antibacterial activity against Gram-negative and Gram-positive pathogens. As per the terms of the
The tie up allows the companies to evaluate the effectiveness of sclerostin antibody on the loss of bone linked with space flight in mice. The sclerostin antibody inhibits
The products of Rowa are intended for the management of medication and retrieval of pre-packaged pharmaceutical inventory. The Rowa products secure and automate large volumes of medications and
The distributing and licensing deal was inked between an affiliate of Sanofi and Theratechnologies on 6 December 2010. Under the agreement, Sanofi has been licensed commercialization rights for
The three products – Adrenalin (epinephrine injection, USP), Coly-Mycin M Parenteral (colistimethate sodium, USP) and Pitocin (oxytocin injection, USP synthetic) – are commonly used in acute care clinical
Jiangsu MingSight-Relin Pharmaceutical will stick to the development standards of both the Chinese SFDA and the US Food and Drug Administration to facilitate the global development of MS-553.
Genetix products include ClonePix and QPix instrument platforms which are designed to address cell lines used in biotherapeutic research. ClonePix is an automated mammalian cell selection platform that
The Pliaglis MAA was filed for the indication of producing local dermal anaesthesia on intact skin in adults prior to superficial dermatological procedures. Previously, Nuvo Research has submitted
In the study, BioLineRx expects to investigate the safety, phamacokinetics and tolerability of BL-1021 in healthy volunteers. The primary endpoints of the study are to assess the safety
Talactoferrin has demonstrated activity in randomized, double-blind, placebo-controlled Phase II studies in non-small cell lung cancer (NSCLC) and in severe sepsis. The study has met the primary endpoint
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.